Rehmann Capital Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.03M | Sell |
2,098
-38
| -2% | -$20.6K | 0.05% | 240 |
|
|
2025
Q4 | $1.24M | Buy |
2,136
+34
| +2% | +$19.2K | 0.06% | 204 |
|
|
2025
Q3 | $1.01M | Buy |
2,102
+88
| +4% | +$41K | 0.06% | 228 |
|
|
2025
Q2 | $817K | Sell |
2,014
-433
| -18% | -$181K | 0.05% | 255 |
|
|
2025
Q1 | $1.22M | Buy |
2,447
+42
| +2% | +$22.7K | 0.08% | 191 |
|
|
2024
Q4 | $1.25M | Sell |
2,405
-163
| -6% | -$89.6K | 0.08% | 183 |
|
|
2024
Q3 | $1.59M | Sell |
2,568
-708
| -22% | -$419K | 0.1% | 151 |
|
|
2024
Q2 | $1.81M | Buy |
3,276
+95
| +3% | +$54.4K | 0.13% | 127 |
|
|
2024
Q1 | $1.85M | Sell |
3,181
-14
| -0.4% | -$7.86K | 0.14% | 125 |
|
|
2023
Q4 | $1.7M | Buy |
3,195
+24
| +0.8% | +$11.6K | 0.14% | 121 |
|
|
2023
Q3 | $1.61M | Sell |
3,171
-127
| -4% | -$67.7K | 0.15% | 116 |
|
|
2023
Q2 | $1.72M | Sell |
3,298
-75
| -2% | -$40.5K | 0.15% | 111 |
|
|
2023
Q1 | $1.94M | Buy |
3,373
+15
| +0.4% | +$8.45K | 0.18% | 106 |
|
|
2022
Q4 | $1.85M | Sell |
3,358
-132
| -4% | -$69.9K | 0.19% | 102 |
|
|
2022
Q3 | $1.77M | Sell |
3,490
-258
| -7% | -$144K | 0.2% | 101 |
|
|
2022
Q2 | $2.04M | Sell |
3,748
-104
| -3% | -$57.2K | 0.22% | 90 |
|
|
2022
Q1 | $2.27M | Sell |
3,852
-96
| -2% | -$55.1K | 0.22% | 90 |
|
|
2021
Q4 | $2.63M | Sell |
3,948
-80
| -2% | -$49.9K | 0.24% | 73 |
|
|
2021
Q3 | $2.3M | Buy |
4,028
+13
| +0.3% | +$7.13K | 0.22% | 81 |
|
|
2021
Q2 | $2.02M | Buy |
4,015
+171
| +4% | +$80.7K | 0.2% | 83 |
|
|
2021
Q1 | $1.75M | Sell |
3,844
-9
| -0.2% | -$4.3K | 0.18% | 91 |
|
|
2020
Q4 | $1.79M | Buy |
3,853
+273
| +8% | +$128K | 0.2% | 88 |
|
|
2020
Q3 | $1.58M | Sell |
3,580
-2,175
| -38% | -$899K | 0.2% | 95 |
|
|
2020
Q2 | $2.09M | Buy |
5,755
+304
| +6% | +$102K | 0.28% | 69 |
|
|
2020
Q1 | $1.55M | Buy |
+5,451
| New | +$1.72M | 0.25% | 75 |
|
|
2019
Q3 | $1.01M | Buy |
3,470
+127
| +4% | +$36.4K | 0.12% | 82 |
|
|
2019
Q2 | $982K | Buy |
3,343
+124
| +4% | +$34.2K | 0.12% | 134 |
|
|
2019
Q1 | $881K | Buy |
3,219
+18
| +0.6% | +$4.48K | 0.12% | 140 |
|
|
2018
Q4 | $717K | Sell |
3,201
-87
| -3% | -$20.4K | 0.11% | 98 |
|
|
2018
Q3 | $803K | Buy |
3,288
+173
| +6% | +$39.8K | 0.11% | 154 |
|
|
2018
Q2 | $645K | Sell |
3,115
-513
| -14% | -$109K | 0.09% | 173 |
|
|
2018
Q1 | $749K | Sell |
3,628
-1
| -0% | -$210 | 0.12% | 146 |
|
|
2017
Q4 | $689K | Sell |
3,629
-72
| -2% | -$13.8K | 0.12% | 158 |
|
|
2017
Q3 | $700K | Sell |
3,701
-633
| -15% | -$115K | 0.13% | 145 |
|
|
2017
Q2 | $756K | Buy |
4,334
+57
| +1% | +$9.57K | 0.14% | 127 |
|
|
2017
Q1 | $657K | Sell |
4,277
-69
| -2% | -$10.5K | 0.11% | 157 |
|
|
2016
Q4 | $613K | Buy |
4,346
+328
| +8% | +$48.4K | 0.11% | 159 |
|
|
2016
Q3 | $639K | Sell |
4,018
-558
| -12% | -$86K | 0.12% | 150 |
|
|
2016
Q2 | $676K | Sell |
4,576
-176
| -4% | -$26K | 0.13% | 144 |
|
|
2016
Q1 | $673K | Buy |
4,752
+1,245
| +36% | +$167K | 0.13% | 130 |
|
|
2015
Q4 | $498K | Sell |
3,507
-99
| -3% | -$13.2K | 0.1% | 160 |
|
|
2015
Q3 | $441K | Buy |
3,606
+233
| +7% | +$30.4K | 0.1% | 158 |
|
|
2015
Q2 | $438K | Sell |
3,373
-12
| -0.4% | -$1.56K | 0.1% | 167 |
|
|
2015
Q1 | $455K | Buy |
3,385
+283
| +9% | +$36.5K | 0.1% | 170 |
|
|
2014
Q4 | $389K | Buy |
3,102
+124
| +4% | +$15.1K | 0.09% | 193 |
|
|
2014
Q3 | $362K | Sell |
2,978
-211
| -7% | -$25.7K | 0.09% | 194 |
|
|
2014
Q2 | $376K | Buy |
3,189
+591
| +23% | +$69.6K | 0.09% | 189 |
|
|
2014
Q1 | $312K | Buy |
+2,598
| New | +$309K | 0.08% | 201 |
|
Other funds holding TMO
VCM
Rehmann Capital Advisory Group's TMO Position: Q1 2026 in Review
Rehmann Capital Advisory Group reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q1 2026, selling an estimated $20.6K and leaving 2,098 shares worth $1.03M. The position accounts for 0.05% of the portfolio, ranked #240.
Rehmann Capital Advisory Group first reported a position in TMO in Q1 2014 and has held it in 48 quarters since. The position peaked at $2.63M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Rehmann Capital Advisory Group held 2,098 shares of Thermo Fisher Scientific worth $1.03M as of Q1 2026.
- Rehmann Capital Advisory Group sold 38 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.6K.
- Thermo Fisher Scientific made up 0.05% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #240 holding.
- Rehmann Capital Advisory Group first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 48 quarters since.
- Rehmann Capital Advisory Group's Thermo Fisher Scientific position peaked at $2.63M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.